ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1786

Lupus Nephritis Is Linked to Immunity to an Intestinal Commensal Lachnospiracaea Species

Gregg J. Silverman1, Doua F. Azzouz2, Hanane El Bannoudi2, Aidana Omarbekova3, Brad H. Rovin4, Roberto Caricchio5, Alexander Alekseyenko6 and Jill P. Buyon2, 1Department of Medicine, New York University School of Medicine, New York, NY, 2Medicine, New York University School of Medicine, New York, NY, 3New York University School of Medicine, New York, NY, 4Ohio State University Medical Center, Columbus, OH, 5Medicine/Rheumatology, Temple University, Philadelphia, PA, 6Medical University of South Carolina, Charleston, SC

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoimmune diseases, Lupus, lupus nephritis and microbiome, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Plenary Session II

Session Type: ACR Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose: A transmissible agent has long been suspected in the pathogenesis of SLE, yet the potential contribution of members of the intestinal microbiome to the immune abnormalities in active SLE has not previously been investigated. We therefore characterized the gut microbiota of patients with SLE, with special interest in those with Lupus nephritis (LN), a clinical feature too commonly associated with great morbidity and early mortality.

Methods: Blood and fecal samples from SLE patients were obtained, with the exclusion of patients with selective IgA deficiency, or history of prior cytotoxic drugs, or antibiotics within four months. Fecal 16S rRNA next generation sequencing was performed. Sera samples were profiled for autoantibodies. In addition, sera from two independent lupus cohorts were studied for validation.

Results: Compared to controls, the intestinal microbiome from SLE patients (N=61) showed decreased species richness diversity. The microbiota of patients in clinical remission (based on SLEDAI) were most similar to healthy controls, while reductions in taxonomic complexity were most pronounced in those with high disease activity. Notably, SLE patients had an overall 5-fold greater representation of a particular species in the Blautia genus of the Lachnospiracaea family of obligate anaerobic Gram-positive cocci. There were reciprocal significant contractions of two other commensal species with putative protective properties. Abundance of the Lachnospiracaea species significantly correlated with serum IgG to a cell wall moiety from a strain of this same species (P=0.002, N=61, Spearman) but not with 7 other strains. There was also a significant correlation between the distribution of SLEDAI scores and levels of these circulating anti-strain IgG antibodies (P=0.02, N=48). Using bacterial antigen treated with DNAse/proteinase K, levels of IgG anti-strain antibodies were significantly higher in those with active nephritis at time of sampling compared to SLE without renal activity (Cohort 1 P=0.01 N=48; Cohort 2 P=0.006, N=28, Mann-Whitney). Levels of anti- strain antibodies also significantly correlated with high-titer serum IgG to native DNA (P<0.0001, N=27), and inversely correlated with C3 and C4 (each P<0.01, N=61). High titers of these anti-bacterial antibodies were found in patients with active Class III, IV and V LN (Cohort 3).

Conclusion: These findings suggest a novel paradigm for the pathogenesis of LN in which specific strains of common intestinal commensal bacteria contribute to the immune-complex mediated disease process responsible for glomerulonephritis (GN). This is reminiscent of poststreptococcal GN, although in LN the postulated intestinal bacterial dysbioses and microbial expansion appear to occur without outward signs and symptoms of clinical infection.


Disclosure: G. J. Silverman, None; D. F. Azzouz, None; H. El Bannoudi, None; A. Omarbekova, None; B. H. Rovin, None; R. Caricchio, None; A. Alekseyenko, None; J. P. Buyon, None.

To cite this abstract in AMA style:

Silverman GJ, Azzouz DF, El Bannoudi H, Omarbekova A, Rovin BH, Caricchio R, Alekseyenko A, Buyon JP. Lupus Nephritis Is Linked to Immunity to an Intestinal Commensal Lachnospiracaea Species [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/lupus-nephritis-is-linked-to-immunity-to-an-intestinal-commensal-lachnospiracaea-species/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lupus-nephritis-is-linked-to-immunity-to-an-intestinal-commensal-lachnospiracaea-species/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology